Malabsorption of liposoluble vitamins in a child with bile acid deficiency.
A male born to first cousins presented at 12 months with hypocalcemic convulsions, rickets, epistaxis due to vitamin K deficiency, and extremely low serum levels of beta-carotene and vitamin A. Liver function was altered moderately (glutamic-oxaloacetic transaminase, 55 U/L; glutamic-pyruvic transaminase, 37 U/L; lactate dehydrogenase, 255 U/L; alkaline phosphatase, 437 U/L). To correct the deficiencies, 8,000 IU vitamin D/day, 10,000 IU vitamin A/day, and intramuscular administration of vitamin K1 were required. At 9 years, he presented signs of neuromuscular affection, and the serum vitamin E level (measured for the first time) was extremely low. Classic lipid malabsorption syndromes (abetalipoproteinemia, chronic cholestasis, mucoviscidosis, coeliac disease, Whipple's disease) were excluded by appropriate examinations. Composition of duodenal bile acids was characterized by undetectable levels of cholic acid metabolites, and only chenodeoxycholic acid metabolites were present. Serum total bile acid concentration was normal, with an atypical low cholic acid/chenodeoxycholic acid ratio and abnormal presence of 3 beta-OH-delta 5-cholenic acid and 6-OH-bile acids. Urinary bile acid composition was also characterized by elevated 6-OH-bile acids. Known enzymopathies of the bile acid synthetic pathway were excluded (cerebrotendinous xanthomatosis, cerebro-hepato-renal syndrome of Zellweger, coprostanic acidemia). Bile acid pool sizes were determined by using stable isotopes: cholic acid pool size [2.90 (N, 32 +/- 16) microM/kg] and chenodeoxycholic acid pool size [10.8 (N, 32.6 +/- 9.9) microM/kg] were extremely low; fractional turnover rates of both bile acids were in a normal range.(ABSTRACT TRUNCATED AT 250 WORDS)
D000293:Adolescent; D001647:Bile Acids and Salts / Q000032:analysis / Q000172:deficiency*; D002635:Chenodeoxycholic Acid / Q000032:analysis / Q000627:therapeutic use; D002648:Child; D019826:Cholic Acid; D002793:Cholic Acids / Q000032:analysis; D004386:Duodenum / Q000378:metabolism; D006801:Humans; D008055:Lipids; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008286:Malabsorption Syndromes / Q000209:etiology* / Q000378:metabolism; D008297:Male; D012995:Solubility; D014801:Vitamin A / Q000378:metabolism; D014807:Vitamin D / Q000378:metabolism; D014810:Vitamin E / Q000378:metabolism; D014812:Vitamin K / Q000378:metabolism; D014815:Vitamins / Q000378:metabolism*
D001647:Bile Acids and Salts; D002793:Cholic Acids; D008055:Lipids; D014815:Vitamins; D002635:Chenodeoxycholic Acid; D014801:Vitamin A; D014812:Vitamin K; D014807:Vitamin D; D014810:Vitamin E; D019826:Cholic Acid